This week, we’re diving into exciting new MS research on Bruton’s tyrosine kinase (BTK) inhibition and its potential to reduce gray matter lesions in Multiple Sclerosis. Gray matter damage plays a major role in MS progression, yet there are currently no treatments that specifically target it. Using an MS-like disease model, researchers found that BTK inhibitors reduced inflammatory immune cells in the brain and led to fewer, smaller gray matter lesions.

This week, we are exploring the connection between migraines and Multiple Sclerosis (MS).

Natural ways to obtain Vitamin D to reduce the risk of MS